Comparative-Effectiveness Policies Gaining Momentum In Washington
This article was originally published in The Gray Sheet
Executive Summary
Funding comparative-effectiveness research to slow growth in health care spending is building momentum this year among health policy and payor circles
You may also be interested in...
Comparative Effectiveness Could Spur Growth Of Lab Tests, Consultant Says
Laboratory tests are in an "excellent position to displace" more expensive diagnostic procedures, such as imaging, as comparative effectiveness research plays a bigger role in health care decision making, according to a laboratory industry consultant
Comparative Effectiveness Could Spur Growth Of Lab Tests, Consultant Says
Laboratory tests are in an "excellent position to displace" more expensive diagnostic procedures, such as imaging, as comparative effectiveness research plays a bigger role in health care decision making, according to a laboratory industry consultant
Device Makers Cite Special Concerns With Comparative Effectiveness
Comparative effectiveness research, where evidence supporting an established medical therapy is stacked up against that of up-and-coming approaches, is a small but growing element of the U.S. government's strategy for assessing health care